Investor presentation - capital raise
Filed with ASX · · 23 pages · English
This presentation has been prepared by Genetic Signatures Limited (“GSS”). The information contained in this presentation is for information purposes only and has been prepared for use in conjunction with a verbal presentation and should be read in that context. This presentation is proprietary to GSS. It may not be reproduced, disseminated, quoted or referred to, in whole or in part, without the
Genetic Signatures Ltd. on 6ix
In the deck
Earlier from Genetic Signatures
- Genetic Signatures completes $35m placement
- Appendix 4E & Full Year Statutory Accounts
- Appendix 4C and quarterly update
- TGA registration for Respiratory Pathogen Detection Kit
- Appendix 4C - quarterly
Later from Genetic Signatures
- Appendix 4C & quarterly report
- Pause in Trading
- First shipments and regulatory submissions for COVID-19 test
- CE-IVD received for COVID-19 test
- TGA registration of SARS-CoV-2 detection kit
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures